In a 2025 study from McMaster University, researchers analyzed nearly 16,000 adults from NHANES III to check if animal protein raises death risk from heart disease, cancer, or any cause. They found no link to higher mortality—animal protein even cut cancer death risk by a modest but significant amount. Plant protein showed no strong effects, but inflammatory diets with processed meats worsened outcomes.

In 2025, Kuiyuan Zhang and a team from Guizhou University of Traditional Chinese Medicine analyzed data from public databases to study how artificial sweeteners like aspartame, sucralose, and saccharin relate to prostate cancer. They used computer models and lab tests to find key genes and see how sweeteners interact with cancer cells.

In 2025, Giovanni Corsetti and a team from the University of Brescia reviewed studies on amino acid (AA) supplements in cancer patients. They looked at how diet and obesity cause up to 50% of tumors, and how 30-90% of patients get malnutrition from the tumor's high energy use, leading to muscle loss and weakness called sarcopenia or cachexia.

In 2007, Begoña Cerdá and a team studied six volunteers whose fecal samples were incubated with ellagic acid, a soy polyphenol. They found gut bacteria turned it into urolithin, a compound tied to gut inflammation and potential cancer risk in animal studies, with 30-50% more urolithin production in some people, suggesting soy may harm gut health in certain individuals.

In 2025, Yanni Papanikolaou and a team from McMaster University analyzed data from 15,947 adults in the NHANES III survey. They studied how much animal and plant protein people ate, using food diaries and advanced stats to track links with death from heart disease, cancer, or any cause over years.

In 2024, researchers from Shanghai Jiao Tong University analyzed data from over 20,000 U.S. adults (average age 49) in the NHANES survey from 2003-2018, followed until 2019. They compared those eating in an 8-hour window (a common IF method) to those eating over 12-16 hours, adjusting for age, diet, and health factors.

In 2025, Melody Ding and a team from The University of Sydney reviewed 35 studies with over 16,000 adults from 2014-2025. They analyzed how daily step counts affect eight health outcomes, including heart disease, type 2 diabetes, dementia, cancer, depression, falls, physical function, and overall death risk, using data from PubMed and EBSCO CINAHL.

In 2020, Ciara Duffy and a team from the Harry Perkins Institute in Australia studied how honeybee venom and its main part, melittin, affect breast cancer cells. They tested it on lab samples of triple-negative and HER2-enriched breast cancers, two hard-to-treat types, using venom from European honeybees and compared it to bumblebee venom.

In 2025, S. Fattahi and a team studied men with prostate cancer in a randomized cohort, followed over time. They analyzed testosterone levels at diagnosis, adjusting for age, cancer stage, and treatments like hormone therapy, to check links with cancer severity and death rates.

In 2025, Francesco Bettariga and a team from Edith Cowan University studied breast cancer survivors. They tested a single 30-minute session of resistance training (like weights) or high-intensity interval training (HIIT), measuring myokines—proteins from muscles that fight cancer. Blood samples were taken before, right after, and 30 minutes post-workout to see effects on cancer cells in a lab.

In 2025, Hailun Xie and team analyzed 6,568 cancer patients from multiple hospitals. They made an inflammatory score from white blood cell count and C-reactive protein levels in blood, grouping it as mild, moderate, or severe. They tracked survival and nutrition changes using stats like survival curves and risk models.

A 2025 meta-analysis in Frontiers in Nutrition examined multiple trials comparing ketogenic diets (very low-carb, high-fat) with standard diets in cancer patients. The ketogenic group experienced significantly reduced fat mass and visceral fat, lower blood glucose and insulin, and improvements in LDL, total cholesterol, as well as fatigue and insomnia.

A 2025 study reported in ScienceDaily highlights that a single dose of psilocybin produced significant and sustained reductions in depression for cancer patients—lasting up to 2 years after treatment.

A 2025 review in Nutrients by Zhang dives into the crucial roles selenium plays in our bodies. As a key part of selenoproteins, this micronutrient helps balance redox reactions, regulate cell growth, support the immune system, and guard against DNA damage, chronic inflammation, insulin resistance, and neurodegeneration.

A groundbreaking 2-year controlled study on rats—considered the gold standard for cancer research—found that even “safe” levels of glyphosate exposure caused multiple types of cancer, including leukemia, liver, thyroid, kidney, and brain tumors.

Researchers at the University of the Basque Country (2025) have discovered that saliva contains hundreds of DNA methylation markers linked to major diseases—including cancer, coronary artery disease, type 2 diabetes, and Parkinson’s.

A 2023 U.S. Geological Survey study found that at least 45% of the nation’s tap water is estimated to have one or more types of per- and polyfluoroalkyl substances (PFAS). PFAS are used in various products like non-stick cookware and firefighting foams and are known for their persistence in the environment.

Despite marketing claims, major studies show no clear link between UV exposure and melanoma, and outdoor workers may even have lower melanoma rates than those indoors. Meanwhile, most conventional sunscreens contain seed oils that oxidize under heat, hormone-disrupting chemicals like oxybenzone, and titanium dioxide nanoparticles that can reach your brain.